Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
暂无分享,去创建一个
C. Chen | Y. Chao | T. Yeh | L. Chou | W. Jiaang | Wen-Hsing Lin | Chin-Ting Huang | K. Yen | L. Kao | Ching-Ping Chen | S. Hsieh | S. Yen | John Tsu‐An Hsu | C. Chiu | Chun‐Hwa Chen | Ching‐Ping Chen